Dear All, The Wellcome Trust Drug-Resistant Infections team wants to understand what researchers in academia and SMEs need to enable them to be better able to make progress with their early antibiotic discovery projects. Although some programs are now in place (e.g., the accelerator support provided by CARB-X), what are the remaining barriers? To help
Dear All, Just below my signature, you will find the details of WHO’s search for a consultant to help them create the global governance for AMR-related work. Sorting through the acronyms takes a bit of effort, but this role will sit at the heart of the global OneHealth agenda of the UN IACG (Interagency Coordination
Dear All, Wow, a news-heavy day … at least two more newsletters this weekend, I think. See below my signature a posting for a 6-month consultancy in Geneva with WHO to support the antimicrobial stewardship activities of the WHO’s Department of Global Coordination and Partnership on Antimicrobial Resistance. Deadline is 10 July 2020 for applications.
Dear All, As recently highlighted in the 2019 reports from the World Bank (Pulling Together to Beat Superbugs, link) and the UN Inter-Agency Coordination Group (No Time to Wait: Securing the Future from Drug-Resistant Infections, link), many countries are not able to implement the AMR-focused National Action Plans called for by the WHO in 2015
Dear All, First up today is a very interesting new workshop from FDA on 1-2 Sep entitled “Advancing the Development of Pediatric Therapeutics (ADEPT 7) Complex Innovative Trial Design.” In brief: “The Complex Innovative Trial Design Pilot Meeting Program (CID Program) facilitates and advances the use of complex and innovative trial designs that have the potential
Dear All, Today we have two interwoven topics to consider: An analysis of research priorities (not all technical!) and a triad of related initiatives, each of which comes with an opportunity for you to starting working on some of those priorities! First up, we have an excellent new paper summarizing the perspective of 32 experts
Dear All: Wellcome Trust (WT) is seeking a Science Lead for WT’s Drug-Resistant Program (DRI) programme. This is a very senior role with global reach: the Science Lead reports to the Head of the DRI programme and has direct responsibility for leading the team that executes and monitors the DRI science strategy. The DRI program spans 4 pillars:
Dear All: Just released today is an RFP (see text just below my signature) to develop a business plan for the design, funding, and implementation of a sustainable clinical trial network for developing new antibacterial agents. The core of this idea emerged in early 2016 based on debates about the potential value of a network focused on a
Dear All: Building on my recent note about a search for the G20 secretariat lead, we now have CARB-X getting into job creation mode by posting 8 positions across 5 different job openings: Accelerator Lead: coordinates the work of the growing accelerator network for all CARB-X-funded companies. Support Team Lead (three positions): takes responsibility for managing the full range of
Dear All: The new Novo REPAIR impact fund ($165m over 5 years for antibacterials) is now open for applications — see the template at this link. Applications are due 15 May. Relatedly, Novo would like to hire a Senior Associate to help manage the fund. Primary qualifications are (1) scientific understanding of microbiology or a related
Using ideas to connect, create, and inspire
Supported by the Wellcome Trust